Temozolomide (Ascend Laboratories, LLC)
Welcome to the PulseAid listing for the Temozolomide drug offered from Ascend Laboratories, LLC. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ascend Laboratories, LLC |
NON-PROPRIETARY NAME: | Temozolomide |
SUBSTANCE NAME: | TEMOZOLOMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-04-28 |
END MARKETING DATE: | 0000-00-00 |
Temozolomide HUMAN PRESCRIPTION DRUG Details:
Item Description | Temozolomide from Ascend Laboratories, LLC |
LABELER NAME: | Ascend Laboratories, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2017-04-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67877-537_4f2ccb25-52e5-4234-9d38-a257e7329cbc |
PRODUCT NDC: | 67877-537 |
APPLICATION NUMBER: | ANDA207658 |
Other TEMOZOLOMIDE Pharmaceutical Manufacturers / Labelers: